论文部分内容阅读
原发性支气管肺癌是目前世界各地最为常见的恶性肿瘤之一,其发病率在我国城市常见恶性肿瘤中居首位,严重威胁公众健康和生命安全。目前,西医治疗肺癌的常规方法包括:手术、放疗、化疗及分子靶向药物治疗。中医无“肺癌”之病名,其对该病的论述散见于“肺积”、“积聚”、“咳嗽”、“咯血”、“胸痛”等文献。经过数十年的探索与实践,中医药在治疗肺癌的基础性研究和临床经验积累上,取得了长足进步,体现出了中医疗法在肺癌治疗中的独特作用。
Primary bronchial lung cancer is one of the most common malignant tumors in the world at present, and its incidence is the highest among the common malignant tumors in our country, which seriously threatens public health and life safety. At present, Western conventional treatment of lung cancer include: surgery, radiotherapy, chemotherapy and molecular targeted drug treatment. Chinese medicine has no “lung cancer” disease name, its discussion of the disease scattered in the “lung accumulation”, “accumulation”, “cough”, “hemoptysis”, “chest pain” and other documents . After decades of exploration and practice, Chinese medicine has made great strides in the basic research and clinical experience in the treatment of lung cancer, reflecting the unique role of Chinese medicine in the treatment of lung cancer.